ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: PUB288

A Case of Dialysis-Dependent Rapidly Progressing C3 Glomerulonephritis

Session Information

Category: Glomerular Diseases

  • 1402 Glomerular Diseases: Clinical, Outcomes, and Trials

Authors

  • Hirpara, Samir, Inova Fairfax Hospital, Falls Church, Virginia, United States
  • Hedden, Morgan, Inova Fairfax Hospital, Falls Church, Virginia, United States
  • Nguyen, Alison, Inova Fairfax Hospital, Falls Church, Virginia, United States
  • Regunathan-Shenk, Renu, Virginia Nephrology Group, Fairfax, Virginia, United States
  • Modlinger, Paul S., Virginia Nephrology Group, Fairfax, Virginia, United States
Introduction

We present a case of dialysis-dependent rapidly progressing C3 glomerulonephritis (GN) without evidence of infection or paraproteinemia.

Case Description

Our patient (pt) is a 72-year-old male who presented with a subacute history of weight loss, fatigue, bilateral flank pain, and anasarca. Given his non-specific presentation, he initially went to an oncologist. Workup including bone marrow biopsy and serum protein electrophoresis was unremarkable aside from a creatinine elevation from a baseline of 0.8 (1 month prior) to 7.4 mg/dL. After admission to the hospital, he initiated hemodialysis for acute kidney injury. Autoimmune evaluation revealed negative anti-nuclear cytoplasmic antibody (ANCA), negative double-stranded DNA, low complement C3 (25 mg/dL), normal complement C4 (17 mg/dL), and anti-nuclear antibody testing (ANA) was weakly positive (1:160, speckled appearance). Repeat serum protein electrophoresis with immunofixation was negative. Infectious evaluation including urine culture, blood cultures, and a transthoracic echocardiogram was also negative. Renal biopsy revealed crescentic C3 GN. He was started on prednisone with plans to initiate cyclophosphamide pending insurance clearance. However, within 4 weeks, the pt recovered off of dialysis prior to the initiation of cyclophosphamide. The patient has continued on a steroid taper and was initiated on mycophenolate mofetil 1,500 mg twice daily. His most recent metabolic panel showed a creatinine of 0.78 mg/dL and persistent microscopic hematuria at approximately 5 months since diagnosis.

Discussion

To our knowledge, this is the first reported case of dialysis-dependent C3 GN which improved with steroid treatment alone. It remains unclear if the patient experienced post-infectious GN from an unidentified infection versus an idiopathic C3 GN with rapid progression.